ABM Clinical Protocol #10: Breastfeeding the Late Preterm (34–36 6/7 Weeks of Gestation) and Early Term Infants (37–38 6/7 Weeks of Gestation), Second Revision 2016

Breastfeeding ◽  
2022 ◽  
pp. 862-869
Author(s):  
Eyla G. Boies ◽  
Yvonne E. Vaucher
Birth ◽  
2014 ◽  
Vol 41 (4) ◽  
pp. 330-338 ◽  
Author(s):  
Neera K. Goyal ◽  
Laura B. Attanasio ◽  
Katy B. Kozhimannil

2013 ◽  
Vol 31 (04) ◽  
pp. 269-278 ◽  
Author(s):  
Prakesh Shah ◽  
Vibhuti Shah ◽  
Xiang Ye ◽  
Shoo Lee ◽  
Ann Jefferies ◽  
...  

2015 ◽  
Vol 35 (8) ◽  
pp. 660-664 ◽  
Author(s):  
N Z Rabie ◽  
T M Bird ◽  
E F Magann ◽  
R W Hall ◽  
S S McKelvey

Children ◽  
2021 ◽  
Vol 8 (4) ◽  
pp. 272
Author(s):  
Zeyar T. Htun ◽  
Jacqueline C. Hairston ◽  
Cynthia Gyamfi-Bannerman ◽  
Jaime Marasch ◽  
Ana Paula Duarte Ribeiro

Respiratory distress in late-preterm and early term infants generally may warrant admission to a special care nursery or an intensive care unit. In particular, respiratory distress syndrome and transient tachypnea of the newborn are the two most common respiratory morbidities. Antenatal corticosteroids (ACS) facilitate surfactant production and lung fluid resorption. The use of ACS has been proven to be beneficial for preterm infants delivered at less than 34 weeks’ gestation. Literature suggests that the benefits of giving antenatal corticosteroids may extend to late-preterm and early term infants as well. This review discusses the short-term benefits of ACS administration in reducing respiratory morbidities, in addition to potential long term adverse effects. An update on the current practices of ACS use in pregnancies greater than 34 weeks’ gestation and considerations of possibly extending versus restricting this practice to certain settings will also be provided.


Sign in / Sign up

Export Citation Format

Share Document